Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Qiagen N.V (QGEN) EBT: 2009-2025

Historic EBT for Qiagen N.V (QGEN) over the last 9 years, with Sep 2025 value amounting to $264.5 million.

  • Qiagen N.V's EBT rose 8.34% to $264.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $770.4 million, marking a year-over-year increase of 9.29%. This contributed to the annual value of $121.1 million for FY2024, which is 71.81% down from last year.
  • As of Q3 2025, Qiagen N.V's EBT stood at $264.5 million, which was up 1.55% from $260.5 million recorded in Q2 2025.
  • In the past 5 years, Qiagen N.V's EBT registered a high of $264.5 million during Q3 2025, and its lowest value of $99.8 million during Q3 2023.
  • Moreover, its 3-year median value for EBT was $122.7 million (2024), whereas its average is $168.4 million.
  • Its EBT has fluctuated over the past 5 years, first crashed by 36.00% in 2022, then surged by 144.59% in 2024.
  • Quarterly analysis of 5 years shows Qiagen N.V's EBT stood at $165.4 million in 2021, then tumbled by 36.00% to $105.8 million in 2022, then climbed by 12.32% to $118.9 million in 2023, then increased by 5.87% to $125.9 million in 2024, then increased by 8.34% to $264.5 million in 2025.
  • Its EBT was $264.5 million in Q3 2025, compared to $260.5 million in Q2 2025 and $119.5 million in Q1 2025.